PCN94 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)72183-5 ◽

2010 ◽

Vol 13 (3) ◽

pp. A41 ◽

Author(s):

VB Zubek ◽

F Khan

Keyword(s):

Prostate Cancer ◽

Risk Stratification ◽

Cancer Patients ◽

Cost Minimization ◽

Intermediate Risk ◽

Cost Minimization Analysis ◽

Risk Prostate Cancer

Download Full-text

PMD27 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS BASED ON RESULTS FROM PHYSICIAN CASE STUDIES

Value in Health ◽

10.1016/j.jval.2011.02.467 ◽

2011 ◽

Vol 14 (3) ◽

pp. A84 ◽

Author(s):

V.B. Zubek ◽

F. Khan ◽

H. Karvir

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Risk Stratification ◽

Cancer Patients ◽

Case Studies ◽

Cost Minimization ◽

Cost Minimization Analysis ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Do Current Clinical Risk Stratification Models for Intermediate-Risk Prostate Cancer Patients Actually Predict for Unfavorable Pathological Features on Radical Prostatectomy Specimens?

Brachytherapy ◽

10.1016/j.brachy.2016.04.345 ◽

2016 ◽

Vol 15 ◽

pp. S187

Author(s):

Shane Mesko ◽

John V. Hegde ◽

Mitchell Kamrava

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Risk Stratification ◽

Cancer Patients ◽

Intermediate Risk ◽

Pathological Features ◽

Clinical Risk ◽

Risk Prostate Cancer

Download Full-text

Abstract 4347: A novel live cell diagnostic platform measuring phenotypic biomarkers using objective algorithmic analysis enables further risk stratification for intermediate-risk prostate cancer patients

10.1158/1538-7445.am2015-4347 ◽

2015 ◽

Author(s):

Michael S. Manak ◽

Wendell R. Su ◽

Andrew Min ◽

Brad J. Hogan ◽

Matthew J. Whitfield ◽

...

Keyword(s):

Prostate Cancer ◽

Risk Stratification ◽

Cancer Patients ◽

Live Cell ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Algorithmic Analysis

Download Full-text

The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience

The Aging Male ◽

10.1080/13685538.2021.1948992 ◽

2021 ◽

Vol 24 (1) ◽

pp. 50-57

Author(s):

Selvi Dinçer ◽

Emre Uysal ◽

Tanju Berber ◽

Mustafa Halil Akboru

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Hypofractionated Radiotherapy ◽

Intermediate Risk ◽

Single Center ◽

Single Center Experience ◽

Risk Prostate Cancer

Download Full-text

Clinical significance of unfavorable findings in intermediate‐risk prostate cancer patients for predicting treatment outcomes after contemporary, dose‐escalated multimodal radiotherapy

The Prostate ◽

10.1002/pros.24289 ◽

2021 ◽

Author(s):

Fumihiko Urabe ◽

Kenta Miki ◽

Takahiro Kimura ◽

Hiroshi Sasaki ◽

Kojiro Tashiro ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Outcomes ◽

Cancer Patients ◽

Clinical Significance ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Robustness of the Phoenix Biochemical Failure Definition 10 Years after Completing Dose Escalated Radiotherapy in a Cohort of Intermediate Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.1866 ◽

2019 ◽

Vol 105 (1) ◽

pp. E261

Author(s):

G.A. Aljawi ◽

I. Busca ◽

R.M. MacRae ◽

L. Eapen

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Biochemical Failure ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Download Full-text

Abstract 4308: 3D nuclear telomeric signatures define circulating tumor cells (CTCs) and characterize CTC subpopulations in intermediate risk prostate cancer patients

10.1158/1538-7445.am2014-4308 ◽

2014 ◽

Author(s):

Awe A. Julius ◽

Adam Yan ◽

Nidhi Shah ◽

Klewes Ludger ◽

Alexandra Kuzyk ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients

Translational Andrology and Urology ◽

10.21037/tau.2020.01.28 ◽

2020 ◽

Vol 9 (2) ◽

pp. 437-444

Author(s):

Gang Song ◽

Mingjian Ruan ◽

He Wang ◽

Zhiyong Lin ◽

Xiaoying Wang ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Predictive Model ◽

Cancer Patients ◽

Nerve Sparing ◽

Intermediate Risk ◽

Mri Findings ◽

Prostate Mri ◽

Risk Prostate Cancer

Download Full-text

Combined clinical characteristics and multiparametric MRI parameters for prediction of cribriform morphology in intermediate-risk prostate cancer patients

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2019.09.002 ◽

2020 ◽

Vol 38 (4) ◽

pp. 216-224 ◽

Author(s):

Jie Gao ◽

Qing Zhang ◽

Yao Fu ◽

Wei Wang ◽

Chengwei Zhang ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Clinical Characteristics ◽

Multiparametric Mri ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts

Journal of Contemporary Brachytherapy ◽

10.5114/jcb.2015.56763 ◽

2015 ◽

Vol 6 ◽

pp. 430-436 ◽

Author(s):

Gregory S. Merrick ◽

Wayne M. Butler ◽

Robert W. Galbreath ◽

Ryan Fiano ◽

Edward Adamovich

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text